Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma

New perspectives in the post IO setting

Date

14 Sep 2024

Session

Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma

Topics

Tumour Site

Renal Cell Cancer

Presenters

Manuela Schmidinger

Authors

M. Schmidinger

Author affiliations

  • Medicine I, Clinical Division Of Oncology, Vienna General Hospital (AKH) - Medizinische Universität Wien, 1090 - Vienna/AT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and Introduction

Presenter: Toni Choueiri

Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma

Resources:

Webcast

aRCC 1L treatment selection

Presenter: Brian Rini

Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma

Resources:

Webcast

Round table case discussions, Q&A

Presenter: Toni Choueiri

Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma

Resources:

Webcast

Summary and key takeaways

Presenter: Manuela Schmidinger

Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.